FDA
approval
· 2023-10-24
FDA Approved: PROBENECID AND COLCHICINE — Original Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved a generic fixed-dose combination tablet of probenecid and colchicine under ANDA217030 from Rising Pharma Holdings, Inc. for the treatment of gout.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PROBENECID AND COLCHICINE (PROBENECID AND COLCHICINE)